2 not yet recruiting, 2 recruiting, 1 unknown. 2 Not applicable, 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Not yet recruiting 1, Unknown 1 |
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Tongue Squamous Cell Carcinoma: new trials by email Literature Review of Tongue Squamous Cell Carcinoma trials Research Report on Tongue Squamous Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Resection and Defect Repair of Oral Cancer Aided by Mixed Reality Technology Unreal Engine 5 (UE5)-based Mixed Reality (MR) Technology-assisted Resection of Oral Cancer and Defect Reconstruction, Virtual Surgical Guide Technology-assisted Resection of Oral Cancer and Defect Reconstruction - Tongue Squamous Cell Carcinoma, Mixed Reality | Not applicable | Not yet recruiting | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 30 | 2026-04-01 | 2026-03-20 |
| Lingual Nerve Disruption to Augment Neoadjuvant Chemoimmunotherapy in Locally Advanced Tongue Cancer Lingual Nerve Disruption, Tislelizumab, Albumin-bound Paclitaxel - Tongue Squamous Cell Carcinoma | Phase 2 | Not yet recruiting | Shanghai Zhongshan Hospital | 69 | 2026-01-01 | 2026-01-16 |
| A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas EVOLVE104 - Bladder Cancer, Squamous Cell Carcinoma of the Lung | Phase 1 | Recruiting | EvolveImmune United, Inc | 160 | 2025-11-13 | 2026-09-15 |
| Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer Chest Radiography, Computed Tomography, Fludeoxyglucose F-18 - Buccal Mucosa Squamous Cell Carcinoma, Floor of Mouth Squamous Cell Carcinoma | Phase 2 / Phase 3 | Recruiting | NRG Oncology | 686 | 2020-09-23 | 2026-08-17 |
| Oncological Outcome of Contralateral Submental Artery Island Flap Versus Primary Closure in Tongue Squamous Cell Carcinoma contralateral submental flap for tongue cancer defect, primary closure for tongue cancer defect - Tongue Squamous Cell Carcinoma | Not applicable | Unknown | Cairo University | 64 | 2018-02-21 | 2020-04-14 |
Mouth Neoplasms (2) · Anus Neoplasms (1) · Esophageal Squamous Cell Carcinoma (1) · Squamous Cell Carcinoma of Head and Neck (1) · Urinary Bladder Neoplasms (1)
Head and Neck Neoplasms (3) · Neoplasms (3) · Neoplasms by Site (3) · Carcinoma (2) · Carcinoma, Squamous Cell (2) · Mouth Diseases (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Stomatognathic Diseases (2) · Anus Diseases (1) · Colorectal Neoplasms (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Esophageal Diseases (1) · Esophageal Neoplasms (1)
Albumin-Bound Paclitaxel (1) · Cisplatin (1) · Fluorodeoxyglucose F18 (1) · Magnetic Resonance Spectroscopy (1) · Monitoring, Immunologic (1) · Neck Dissection (1) · Photons (1) · Sentinel Lymph Node Biopsy (1) · X-Rays (1) · acetyl-glycyl-asparagyl-glutaminyl-glutamyl-glutaminyl-valyl-seryl-prolyl-leucyl-threonyl-leucyl-leucyl-lysyl-lysyl-tryptophyl-cysteinyl-Alexa Fluoro 680 C2C2-maleimide conjugate (1) · tislelizumab (1)
Cairo University (1) · EvolveImmune United, Inc (1) · NRG Oncology (1) · Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University (1) · Shanghai Zhongshan Hospital (1)
China (2) · United States (2) · Canada (1) · Egypt (1)
Omer M Jamali, phd student (1) · Stephen Y Lai (1)
U10CA180868 (1)